pharmaceutical profiles

News Headlines

Galapagos Selects Pre-Clinical Candidate Drug for Cachexia
06 January 2009
Galapagos’ pre-clinical candidate G100192 has demonstrated successful Proof of Concept in animal studies.

AVI BioPharma Announces FDA Clearance of IND Applications for Clinical Trials of RNA Therapeutic Agents
31 December 2008
The Company has received verbal clearance from the FDA for its two lead products for Marburg and Ebola virus.